Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Cognitive and Affective Assessments of Multiple Sclerosis (MS) and Neuromyelitis Optica (NMO) Patients Utilizing Computerized Touch Panel-type Screening Tests.
MR venography in patients with multiple sclerosis and correlation with clinical and MRI parameters.
[Thoughts on hot issues of neuromyelitis optica].
Inhibition of UCH-L1 in oligodendroglial cells results in microtubule stabilization and prevents α-synuclein aggregate formation by activating the autophagic pathway: implications for multiple system atrophy.
Oral Administration of Lactococcus lactis Expressing Synthetic Genes of Myelin Antigens in Decreasing Experimental Autoimmune Encephalomyelitis in Rats.
Comments on "first-ever optic neuritis: distinguishing subsequent neuromyelitis optica from multiple sclerosis"
Determinants of disability in multiple sclerosis: an immunological and MRI study.
Addressing the regulatory and scientific challenges in multiple sclerosis - a statement from the EU regulators.
A young patient with visual disturbance.
Gene expression in the spinal cord in female lewis rats with experimental autoimmune encephalomyelitis induced with myelin basic protein.
A tetramethoxychalcone from Chloranthus henryi suppresses lipopolysaccharide-induced inflammatory responses in BV2 microglia.
Role of sphingosine 1-phosphate receptors, sphingosine kinases and sphingosine in cancer and inflammation.
Tropisetron diminishes demyelination and disease severity in an animal model of multiple sclerosis.
T-bet is essential for Th1-mediated, but not Th17-mediated, CNS autoimmune disease.
Systematic Review of the Epidemiology of Urinary Incontinence and Detrusor Overactivity among Patients with Neurogenic Overactive Bladder.
The cost of medication and the cost of treatment are not the same thing for multiple sclerosis.
Incidence and prevalence of multiple sclerosis in the UK 1990-2010: a descriptive study in the General Practice Research Database.
Dimethyl fumarate for treatment of multiple sclerosis: mechanism of action, effectiveness, and side effects.
The contribution of optical coherence tomography in neurodegenerative diseases.
A trifluoromethyl analogue of celecoxib exerts beneficial effects in neuroinflammation.
Walking Distance as a Predictor of Falls in People With Multiple Sclerosis.
Experimental autoimmune encephalomyelitis.
Developmental endothelial locus-1 is a homeostatic factor in the central nervous system limiting neuroinflammation and demyelination.
Vitamin D is associated with degree of disability in patients with fully ambulatory relapsing-remitting multiple sclerosis.
Complex I Subunit Gene Therapy with NDUFA6 Ameliorates Neurodegeneration in EAE.
Pages
« first
‹ previous
…
627
628
629
630
631
632
633
634
635
…
next ›
last »